Bioequivalence of Amphotericin B Liposome for Injection
Status:
Completed
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the bioequivalence of two different
amphotericin B liposome for injection after single IV infusion at the same dose in normal
healthy subjects.